Acuta Capital Partners, LLC Revolution Medicines, Inc. Transaction History
Acuta Capital Partners, LLC
- $70.3 Million
- Q4 2024
A detailed history of Acuta Capital Partners, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 111,700 shares of RVMD stock, worth $4.62 Million. This represents 6.95% of its overall portfolio holdings.
Number of Shares
111,700
Previous 108,000
3.43%
Holding current value
$4.62 Million
Previous $4.89 Million
0.16%
% of portfolio
6.95%
Previous 4.95%
Shares
5 transactions
Others Institutions Holding RVMD
# of Institutions
290Shares Held
168MCall Options Held
260KPut Options Held
620K-
Vanguard Group Inc Valley Forge, PA17.1MShares$706 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$554 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$547 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$447 Million0.09% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$313 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.62B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...